Search research articles
Contact Us
Filters
Showing results (211-220 of 430) with videos related to
Page
of 43
Sort By:
Mycoses
|
November 1, 1993
In vitro susceptibility of Candida albicans, Austria 1992
F Allerberger, A Fassl, D Niederwieser, et al.
Current Problems in Dermatology
|
January 1, 1989
AIDS: T cell activation and viral progression
M P Dierich, C Larcher, B Söldner, et al.
European Journal of Immunology
|
November 1, 1986
Human complement factor H: isolation of cDNA clones and partial cDNA sequence of the 38-kDa tryptic fragment containing the binding site for C3b
T F Schulz, W Schwäble, K K Stanley, et al.
Molecular Immunology
|
November 1, 1986
Cell cycle control of activated, synchronized murine B lymphocytes--roles of macrophages and complement C3
F Melchers, A Erdei, C Corbel, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 17, 1991
[Therapy-refractory fulminant meningococcal sepsis]
A Eigentler, P Lechleitner, C Wiedermann, et al.
Wiener Klinische Wochenschrift
|
March 1, 1985
[Demonstration of a species specific determinant of Bacteroides fragilis lipopolysaccharides using monoclonal antibodies]
T F Schulz, B A Brake, M Sperzel, et al.
Molecular Immunology
|
July 31, 1998
HIV-1 gp41 by a common immunological epitope induces increased levels of antibodies against human interferon-beta in HIV-1 positive individuals
Y H Chen, J N Feng, G Stöckl, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 1, 1996
Prevalence and clinical manifestations of Shiga toxin-producing Escherichia coli infections in Austrian children
F Allerberger, D Rossboth, M P Dierich, et al.
European Journal of Immunology
|
October 1, 1981
Role of beta 1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells
M Schmitt, H H Mussel, K P Hammann, et al.
Infection
|
January 1, 1994
Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation
W M Prodinger, C Larcher, B M Sölder, et al.
Page
of 43
Search research articles
Search
Showing results (211-220 of 430) with videos related to
Sort By:
Page
of 43
Mycoses
|
November 1, 1993
In vitro susceptibility of Candida albicans, Austria 1992
F Allerberger, A Fassl, D Niederwieser, et al.
Current Problems in Dermatology
|
January 1, 1989
AIDS: T cell activation and viral progression
M P Dierich, C Larcher, B Söldner, et al.
European Journal of Immunology
|
November 1, 1986
Human complement factor H: isolation of cDNA clones and partial cDNA sequence of the 38-kDa tryptic fragment containing the binding site for C3b
T F Schulz, W Schwäble, K K Stanley, et al.
Molecular Immunology
|
November 1, 1986
Cell cycle control of activated, synchronized murine B lymphocytes--roles of macrophages and complement C3
F Melchers, A Erdei, C Corbel, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 17, 1991
[Therapy-refractory fulminant meningococcal sepsis]
A Eigentler, P Lechleitner, C Wiedermann, et al.
Wiener Klinische Wochenschrift
|
March 1, 1985
[Demonstration of a species specific determinant of Bacteroides fragilis lipopolysaccharides using monoclonal antibodies]
T F Schulz, B A Brake, M Sperzel, et al.
Molecular Immunology
|
July 31, 1998
HIV-1 gp41 by a common immunological epitope induces increased levels of antibodies against human interferon-beta in HIV-1 positive individuals
Y H Chen, J N Feng, G Stöckl, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 1, 1996
Prevalence and clinical manifestations of Shiga toxin-producing Escherichia coli infections in Austrian children
F Allerberger, D Rossboth, M P Dierich, et al.
European Journal of Immunology
|
October 1, 1981
Role of beta 1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells
M Schmitt, H H Mussel, K P Hammann, et al.
Infection
|
January 1, 1994
Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation
W M Prodinger, C Larcher, B M Sölder, et al.
Page
of 43